600
Participants
Start Date
June 30, 2007
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Pioglitazone and metformin
Pioglitazone 15 mg /metformin 850 mg combination, tablets, orally, twice daily for up to 24 weeks.
Pioglitazone
Pioglitazone 15 mg, tablets, orally, twice daily for up to 24 weeks.
Metformin
Metformin 850 mg, tablets, orally, twice daily for up to 24 weeks.
Birmingham
Haleyville
Montgomery
Pell City
Phoenix
Tucson
Anaheim
Artesia
Dinuba
Long Beach
Los Angeles
Norwalk
Orange
Santa Ana
Santa Monica
Pueblo
Altamonte Springs
Coral Gables
Hialeah
Miami
Panama City
Plantation
Saint Cloud
St. Petersburg
Tampa
Columbus
Boise
Coeur d'Alene
Chicago
Flossmoor
Peoria
Elkhart
Shawnee
Southfield
Chesterfield
Billings
Elizabeth
Fayetteville
New York
Durham
Pinehurst
Cincinnati
Perrysburg
Zanesville
Oklahoma City
Eugene
Fleetwood
Norristown
Cranston
Simpsonville
Varnville
Fayetteville
Corpus Christi
Dallas
El Paso
Houston
McAllen
Mission
New Braunfels
North Richland Hills
San Antonio
Bountiful
Salt Lake City
Petersburg
Port Orchard
Spokane
Providencia-Santiago
Temuco
Zapopan
Monterrey
Aibonito
Caguas
Ciales
Coto Laurel
Guayma
Guaynabo
Rio Piedras
Lead Sponsor
Takeda
INDUSTRY